The Latest Breaking News from Pfizer

Pfizer postpones FDA request for COVID vaccine for kids under 5

The companies said they will wait for more data on three doses for children under 5.

Axios · Feb 11, 2022

FDA seeks more data before reviewing COVID-19 vaccine for toddlers

The FDA postponed a Feb. 15 review of the Pfizer shots for young children ages 6 months to 4 years old, citing the need for more time.

Roll Call · Feb 11, 2022

Johnson receives ‘partygate’ police questionnaire – as it happened

This blog is now closed

The Guardian - AU · Feb 11, 2022

Japan OKs Pfizer COVID-19 oral pills amid surging infections

Japan has granted fast-track approval to U.S. drug maker Pfizer Inc.’s COVID-19 pill as the country struggles to slow fast-spreading omicron infections

The Independent UK · Feb 10, 2022

A COVID vaccine for children under five is one step closer. Here are five key questions that need answering

Children under five in the US could be getting vaccinated against COVID-19 as soon late February. Here's what we know so far about the jab, and what might happen next.

ABC News · Feb 9, 2022

Under pressure GlaxoSmithKline promises ‘landmark’ year as its outshone by Pfizer

GlaxoSmithKline remained under pressure today after so-so results that drew unfavourable comparisons with US rival Pfizer.

Evening Standard · Feb 9, 2022

How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?

Booster jabs provide up to 70 per cent protection, study finds

The Independent UK · Feb 9, 2022

Pfizer sees Covid-19 drug sales topping $50bn in 2022

NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.

Bangkok Post · Feb 9, 2022

A new top-selling medicine: Pfizer's COVID vaccine

Almost $37 billion this year, and another $32 billion coming next year.

Axios · Feb 8, 2022

Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher

US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%.

Benzinga · Feb 8, 2022